Marian W Fischman
Overview
Explore the profile of Marian W Fischman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez D, Slifstein M, Narendran R, Foltin R, Broft A, Hwang D, et al.
Neuropsychopharmacology
. 2009 Jan;
34(7):1774-82.
PMID: 19177067
The goal of this study was to determine D(1) receptor availability in human cocaine-dependent (CD) subjects and matched healthy controls (HCs). In addition, the CD subjects performed cocaine self-administration sessions...
2.
Yu E, Miotto K, Akerele E, OBrien C, Ling W, Kleber H, et al.
Am J Drug Alcohol Abuse
. 2008 Sep;
34(5):611-6.
PMID: 18821454
Objectives: The objective of this investigation was to characterize the pharmacokinetic profile of lofexidine. Lofexidine is an orally bioavailable alpha 2-adrenergic receptor agonist analogue of clonidine that acts centrally to...
3.
Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, et al.
Drug Alcohol Depend
. 2008 May;
97(1-2):158-68.
PMID: 18508207
Context: Lofexidine is an alpha-2-adrenergic receptor agonist that is approved in the United Kingdom for the treatment of opioid withdrawal symptoms. Lofexidine has been reported to have more significant effects...
4.
Martinez D, Narendran R, Foltin R, Slifstein M, Hwang D, Broft A, et al.
Am J Psychiatry
. 2007 Apr;
164(4):622-9.
PMID: 17403976
Objective: Dopamine is an important mediator of the reinforcing effects of cocaine, and alterations in dopamine function might be involved in cocaine dependence. The goals of the present study were...
5.
Martinez D, Broft A, Foltin R, Slifstein M, Hwang D, Huang Y, et al.
Neuropsychopharmacology
. 2004 Mar;
29(6):1190-202.
PMID: 15010698
Striatal dopamine D2 receptors have been implicated in the neurobiology of cocaine addiction. Previous imaging studies showed reduced striatal D2 receptor availability in chronic cocaine abusers, and animal studies suggested...
6.
Foltin R, Ward A, Collins E, Haney M, Hart C, Fischman M
Exp Clin Psychopharmacol
. 2003 May;
11(2):123-30.
PMID: 12755456
The effects of maintenance on venlafaxine, which blocks both norepinephrine and serotonin reuptake, on the response to smoked cocaine (0, 12, 25, or 50 mg) in 7 opioid-free and 7...
7.
Hart C, Ward A, Haney M, Comer S, Foltin R, Fischman M
Psychopharmacology (Berl)
. 2002 Nov;
164(4):407-15.
PMID: 12457271
Rationale: Although smoked marijuana contains at least 60 cannabinoids, delta(9)-tetrahydrocannabinol (delta(9)-THC) is presumed to be the cannabinoid primarily responsible for many marijuana-related effects, including increased food intake and subjective effects....
8.
Hart C, Haney M, Foltin R, Fischman M
Psychopharmacology (Berl)
. 2002 Nov;
164(4):376-84.
PMID: 12457267
Rationale: The discriminative stimulus effects of N-methyl- D-aspartate (NMDA) antagonists have been assessed in laboratory animals. To date, no published study has assessed their ability to alter methamphetamine-related discriminative stimulus...
9.
Hart C, Haney M, Ward A, Fischman M, Foltin R
Drug Alcohol Depend
. 2002 Jul;
67(3):301-9.
PMID: 12127201
Studies have shown that the Delta(9)-tetrahydrocannabinol (Delta(9)-THC) concentration in marijuana cigarettes is an important factor for the maintenance of marijuana self-administration. Yet, the impact of oral Delta(9)-THC treatment on marijuana...
10.
Comer S, Collins E, Fischman M
J Pharmacol Exp Ther
. 2002 Mar;
301(1):266-76.
PMID: 11907183
Several sources indicate that intravenously administered buprenorphine may have significant abuse liability in humans. The present study evaluated the reinforcing effects of intravenously administered buprenorphine (0, 2, and 8 mg)...